Moore Capital Management LP Lowers Holdings in Chemed Corporation $CHE

Key Points

• Moore Capital Management cut its Chemed stake by 51.2% in the second quarter, selling 5,314 shares and retaining 5,072 shares valued at approximately $2.36 million. Institutional investors collectively own 95.85% of the company.
• Chemed reported stronger-than-expected quarterly results, with EPS of $6.06 versus the $5.60 consensus and revenue of $673.25 million, up 8.8% year over year. The company issued fiscal 2026 EPS guidance of $25.00 to $25.75.
• Chemed increased its quarterly dividend from $0.60 to $0.70 per share, implying an annualized dividend of $2.80 and a 0.5% yield. Analysts remain broadly neutral, with an average “Hold” rating and a $530.75 target price.

Moore Capital Management LP lowered its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 51.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,072 shares of the company's stock after selling 5,314 shares during the quarter. Moore Capital Management LP's holdings in Chemed were worth $2,362,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Quantbot Technologies LP purchased a new position in Chemed during the second quarter valued at $1,726,000. TD Asset Management Inc raised its position in shares of Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company's stock worth $138,860,000 after purchasing an additional 22,715 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in Chemed by 14.5% in the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company's stock valued at $14,985,000 after buying an additional 4,430 shares in the last quarter. Epoch Investment Partners Inc. lifted its stake in Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company's stock valued at $137,945,000 after buying an additional 15,133 shares in the last quarter. Finally, Entropy Technologies LP boosted its holdings in Chemed by 491.7% in the 1st quarter. Entropy Technologies LP now owns 7,195 shares of the company's stock worth $2,718,000 after buying an additional 5,979 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Trading Down 1.0%

CHE opened at $518.26 on Tuesday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The company has a market cap of $6.77 billion, a P/E ratio of 26.03, a PEG ratio of 1.98 and a beta of 0.51. The business's 50-day simple moving average is $511.08 and its 200-day simple moving average is $450.15.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. The firm had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company's revenue was up 8.8% on a year-over-year basis. During the same period last year, the firm posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities research analysts expect that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. This is a positive change from Chemed's previous quarterly dividend of $0.60. Chemed's payout ratio is 14.06%.

Analyst Ratings Changes

CHE has been the topic of several recent research reports. Wall Street Zen upgraded Chemed from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 1st. Weiss Ratings raised Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Royal Bank Of Canada boosted their price target on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Oppenheimer lifted their target price on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research note on Friday, July 31st. Finally, Bank of America restated a "neutral" rating on shares of Chemed in a report on Wednesday, July 29th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $530.75.

Insider Buying and Selling

In other Chemed news, EVP Spencer S. Lee sold 1,000 shares of the company's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the transaction, the executive vice president owned 13,912 shares in the company, valued at approximately $7,526,948.48. This represents a 6.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the sale, the chief executive officer owned 70,418 shares of the company's stock, valued at approximately $37,991,215.18. The trade was a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 6,537 shares of company stock valued at $3,406,014. Company insiders own 3.33% of the company's stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source